Attached files
file | filename |
---|---|
8-K - 8-K - Sigyn Therapeutics, Inc. | s102798_8k.htm |
Exhibit 16.1
March 14, 2016
U.S. Securities and Exchange Commission
Office of the Chief Accountant
100 F Street, N.E.
Washington, DC 20549
Commissioners:
We have read Item 4.01 of Form 8-K, dated March 14, 2016, of Reign Sapphire Corproation. and agree with the statements concerning our Firm contained therein.
Very truly yours,
/s/ Hartley Moore Accountancy Corporation
Hartley Moore Accountancy Corporation